摘要
目的总结甲氨蝶呤(MTX)治疗输卵管妊娠后的生殖状态。方法收集我院1997年3月～2002年8月确诊为输卵管妊娠并符合保守条件的患者61例,应用MTX全身治疗,对其中46例随诊1～7年。结果MTX治疗后宫内妊娠率71.7%,异位妊娠率8.7%。初孕即为输卵管妊娠者,保守治疗后宫内妊娠率为74.2%,再次异位妊娠率6.5%;第2次为输卵管妊娠者,保守治疗后宫内妊娠率为58.3%,再次异位妊娠率16.7%;第3次为输卵管妊娠者,保守治疗后无妊娠。结论选择合适的早期患者采用MTX治疗是安全、价廉、可靠的治疗方法,也可获得满意的远期生殖状态。
Objective To analyze the reproductive prognosis after treatment of tubal pregnancy with the systemic methotrexate (MTX). Methods From March 1997 to August 2002, 61 woman with confirmed tubal pregnancy were treated with systemic MTX, 46 of whom were followed up for 1 to 7 years. Results After MTX treatment, the rate of subsequent intrauterine pregnancies (IUP) was 71.7%, and recurrent extrautenine pregnancies (EP) was 8.7%. For patients with tubal pregnancy at the first pregnancy, IUP was 74.2% and EP was 6.5% after conservative treatment. If the second pregnancy was tubal pregnancy, IUP was 58.3% and EP was 16.7%. Conclusion MTX treatment is safe, low cost and reliable treatment for tubal pregnancy with careful selection, which can obtain satisfactory reproductive prognosis.
出处
《中国妇产科临床杂志》
2005年第4期248-249,264,共3页
Chinese Journal of Clinical Obstetrics and Gynecology
